What's breaking now, across thousands of outlets.
Evommune's Dermira-derived small molecule has failed a Phase 2b test in atopic dermatitis, marking the second mid-stage flop for the experimental drug this summer. The Palo Alto biotech
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
We have put together stories from our coverage on science from the past two weeks to help you stay informed. If you would like to see more of our reporting, please consider subscribing. 1.
We have put together stories from our coverage on science from the past two weeks to help you stay informed. If you would like to see more of our reporting, please consider subscribing. 1.
Jesse Bisiwu’s move to Barcelona was the realisation of a dream for the young forward, according to Feyenoord technical secretary Devy Rigaux, who played an important mentoring role during the…
The term ‘general’ is misleading and can be confusing for patients who may think an internist is the same as a general or family medicine practitioner.
Former US president says doctors helped control the disease and that he's still doing what he cares about, ‘like finishing my memoir’ The post Biden says prostate cancer radiation treatment ‘worked as…
Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.
